摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-(ethylamino)phenyl]propan-1-one | 1399859-11-0

中文名称
——
中文别名
——
英文名称
1-[2-(ethylamino)phenyl]propan-1-one
英文别名
——
1-[2-(ethylamino)phenyl]propan-1-one化学式
CAS
1399859-11-0
化学式
C11H15NO
mdl
——
分子量
177.246
InChiKey
FZHJVECKLWOFJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    吗啉1-[2-(ethylamino)phenyl]propan-1-onebis(1,5-cyclooctadiene)nickel (0)potassium phosphate三甲基膦 作用下, 以 N,N-二甲基甲酰胺氯苯 为溶剂, 反应 48.0h, 以73%的产率得到1-ethylquinolin-4(1H)-one
    参考文献:
    名称:
    Synthesis of 4-Quinolones through Nickel-Catalyzed Intramolecular Amination on the β-Carbon of o-(N-Alkylamino)propiophenones
    摘要:
    o-(N-Alkylamino)propiophenones are converted into 4-quinolones in the presence of chlorobenzene, potassium phosphate, morpholine, and nickel(0) catalyst. The reaction proceeds through the nickel-catalyzed formation of beta-enaminones from o-(N-alkylamino)propiophenones and morpholine, followed by the intramolecular transamination.
    DOI:
    10.1055/s-0031-1291146
  • 作为产物:
    描述:
    N-乙基苯胺丙腈三氯化硼 、 aluminum (III) chloride 作用下, 以 为溶剂, 以19%的产率得到1-[2-(ethylamino)phenyl]propan-1-one
    参考文献:
    名称:
    Synthesis of 4-Quinolones through Nickel-Catalyzed Intramolecular Amination on the β-Carbon of o-(N-Alkylamino)propiophenones
    摘要:
    o-(N-Alkylamino)propiophenones are converted into 4-quinolones in the presence of chlorobenzene, potassium phosphate, morpholine, and nickel(0) catalyst. The reaction proceeds through the nickel-catalyzed formation of beta-enaminones from o-(N-alkylamino)propiophenones and morpholine, followed by the intramolecular transamination.
    DOI:
    10.1055/s-0031-1291146
点击查看最新优质反应信息

文献信息

  • 11-Beta HSD1 inhibitors
    申请人:Xiang Shaoyun Jason
    公开号:US20060025445A1
    公开(公告)日:2006-02-02
    This invention relates to inhibiting 11-beta HSD1.
    这项发明涉及抑制11-beta HSD1。
  • Inhibitors of Ion Channels
    申请人:Marron Brian Edward
    公开号:US20130072471A1
    公开(公告)日:2013-03-21
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了在通过抑制电压门控通道中的钠离子流来治疗疾病方面有用的化合物、组合物和方法。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻断与所示条件的发生或复发相关的通道来实现。本发明的化合物、组合物和方法特别适用于通过抑制电压门控通道中的离子流来治疗神经病性或炎症性疼痛。
  • INHIBITORS OF ION CHANNELS
    申请人:Marron Brian Edward
    公开号:US20090143358A1
    公开(公告)日:2009-06-04
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了化合物、组合物和方法,通过抑制电压门控通道中的钠离子流来治疗疾病。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻止与所示疾病的发生或复发有关的通道。本发明的化合物、组合物和方法特别适用于通过抑制电压门控通道中的离子流来治疗神经病理性或炎症性疼痛。
  • US8357711B2
    申请人:——
    公开号:US8357711B2
    公开(公告)日:2013-01-22
  • US8741934B2
    申请人:——
    公开号:US8741934B2
    公开(公告)日:2014-06-03
查看更多